{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:58:43Z","timestamp":1783040323814,"version":"3.54.6"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13023-017-0595-3","type":"journal-article","created":{"date-parts":[[2017,3,7]],"date-time":"2017-03-07T00:09:23Z","timestamp":1488845363000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The efficacy of the modified Atkins diet in North Sea Progressive Myoclonus Epilepsy: an observational prospective open-label study"],"prefix":"10.1186","volume":"12","author":[{"given":"Martje E.","family":"van Egmond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amerins","family":"Weijenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margreet E.","family":"van Rijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Willem J.","family":"Elting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannette M.","family":"Gelauff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodi","family":"Zutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A.","family":"Sival","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roald A.","family":"Lambrechts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina A. J.","family":"Tijssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oebele F.","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom J.","family":"de Koning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,7]]},"reference":[{"key":"595_CR1","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ajhg.2011.04.011","volume":"88","author":"MA Corbett","year":"2011","unstructured":"Corbett MA, Schwake M, Bahlo M, Dibbens LM, Lin M, Gandolfo LC, Vears DF, O\u2019Sullivan JD, Robertson T, Bayly MA, Gardner AE, Vlaar AM, Korenke GC, Bloem BR, de Coo IF, Verhagen JM, Lehesjoki AE, Gecz J, Berkovic SF. A mutation in the Golgi Qb-SNARE gene GOSR2 causes progressive myoclonus epilepsy with early ataxia. Am J Hum Genet. 2011;88:657\u201363.","journal-title":"Am J Hum Genet"},{"key":"595_CR2","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/brain\/awt021","volume":"136","author":"L Boisse Lomax","year":"2013","unstructured":"Boisse Lomax L, Bayly MA, Hjalgrim H, Moller RS, Vlaar AM, Aaberg KM, Marquardt I, Gandolfo LC, Willemsen M, Kamsteeg EJ, O\u2019Sullivan JD, Korenke GC, Bloem BR, de Coo IF, Verhagen JM, Said I, Prescott T, Stray-Pedersen A, Rasmussen M, Vears DF, Lehesjoki AE, Corbett MA, Bahlo M, Gecz J, Dibbens LM, Berkovic SF. \u2018North Sea\u2019 progressive myoclonus epilepsy: phenotype of subjects with GOSR2 mutation. Brain. 2013;136:1146\u201354.","journal-title":"Brain"},{"key":"595_CR3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/mds.25704","volume":"29","author":"ME Egmond Van","year":"2014","unstructured":"Van Egmond ME, Verschuuren-Bemelmans CC, Nibbeling EA, Elting JW, Sival DA, Brouwer OF, de Vries JJ, Kremer HP, Sinke RJ, Tijssen MA, de Koning TJ. Ramsay Hunt syndrome: clinical characterization of progressive myoclonus ataxia caused by GOSR2 mutation. Mov Disord. 2014;29:139\u201343.","journal-title":"Mov Disord"},{"key":"595_CR4","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1136\/practneurol-2014-000994","volume":"15","author":"N Malek","year":"2015","unstructured":"Malek N, Stewart W, Greene J. The progressive myoclonic epilepsies. Pract Neurol. 2015;15:164\u201371.","journal-title":"Pract Neurol"},{"key":"595_CR5","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.seizure.2012.08.009","volume":"21","author":"A Fujimoto","year":"2012","unstructured":"Fujimoto A, Yamazoe T, Yokota T, Enoki H, Sasaki Y, Nishimura M, Yamamoto T. Clinical utility of vagus nerve stimulation for progressive myoclonic epilepsy. Seizure. 2012;21:810\u20132.","journal-title":"Seizure"},{"key":"595_CR6","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S1474-4422(08)70092-9","volume":"7","author":"EG Neal","year":"2008","unstructured":"Neal EG, Chaffe H, Schwartz RH, Lawson MS, Edwards N, Fitzsimmons G, Whitney A, Cross JH. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol. 2008;7:500\u20136.","journal-title":"Lancet Neurol"},{"key":"595_CR7","doi-asserted-by":"crossref","unstructured":"Lambrechts DA, de Kinderen RJ, Vles JS, de Louw AJ, Aldenkamp AP, Majoie HJ. A randomized controlled trial of the ketogenic diet in refractory childhood epilepsy. Acta Neurol Scand. 2017;135:231-9.","DOI":"10.1111\/ane.12592"},{"key":"595_CR8","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1542\/peds.102.6.1358","volume":"102","author":"JM Freeman","year":"1998","unstructured":"Freeman JM, Vining EP, Pillas DJ, Pyzik PL, Casey JC, Kelly LM. The efficacy of the ketogenic diet-1998: a prospective evaluation of intervention in 150 children. Pediatrics. 1998;102:1358\u201363.","journal-title":"Pediatrics"},{"issue":"Suppl 11","key":"595_CR9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1528-1157.44.s11.5.x","volume":"44","author":"JW Wheless","year":"2003","unstructured":"Wheless JW, Sankar R. Treatment strategies for myoclonic seizures and epilepsy syndromes with myoclonic seizures. Epilepsia. 2003;44 Suppl 11:27\u201337.","journal-title":"Epilepsia"},{"key":"595_CR10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.seizure.2009.01.004","volume":"18","author":"N Porta","year":"2009","unstructured":"Porta N, Vallee L, Boutry E, Fontaine M, Dessein AF, Joriot S, Cuisset JM, Cuvellier JC, Auvin S. Comparison of seizure reduction and serum fatty acid levels after receiving the ketogenic and modified Atkins diet. Seizure. 2009;18:359\u201364.","journal-title":"Seizure"},{"key":"595_CR11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/0883073810375718","volume":"26","author":"EH Kossoff","year":"2011","unstructured":"Kossoff EH, Dorward JL, Turner Z, Pyzik PL. Prospective study of the modified atkins diet in combination with a ketogenic liquid supplement during the initial month. J Child Neurol. 2011;26:147\u201351.","journal-title":"J Child Neurol"},{"key":"595_CR12","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1528-1167.2008.01765.x","volume":"50","author":"EH Kossoff","year":"2009","unstructured":"Kossoff EH, Zupec-Kania BA, Amark PE, Ballaban-Gil KR, Christina Bergqvist AG, Blackford R, Buchhalter JR, Caraballo RH, Helen Cross J, Dahlin MG, Donner EJ, Klepper J, Jehle RS, Kim HD, Christiana Liu YM, Nation J, Nordli Jr DR, Pfeifer HH, Rho JM, Stafstrom CE, Thiele EA, Turner Z, Wirrell EC, Wheless JW, Veggiotti P, Vining EP, Charlie Foundation, Practice Committee of the Child Neurology Society, Practice Committee of the Child Neurology Society, International Ketogenic Diet Study Group. Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study Group. Epilepsia. 2009;50:304\u201317.","journal-title":"Epilepsia"},{"key":"595_CR13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1367\/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2","volume":"3","author":"JW Varni","year":"2003","unstructured":"Varni JW, Burwinkle TM, Seid M, Skarr D. The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambul Pediatr. 2003;3:329\u201341.","journal-title":"Ambul Pediatr"},{"key":"595_CR14","first-page":"361","volume":"89","author":"SJ Frucht","year":"2002","unstructured":"Frucht SJ, Leurgans SE, Hallett M, Fahn S. The Unified Myoclonus Rating Scale. Adv Neurol. 2002;89:361\u201376.","journal-title":"Adv Neurol"},{"key":"595_CR15","first-page":"28","volume":"4","author":"J Busner","year":"2007","unstructured":"Busner J, Targum SD. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont). 2007;4:28\u201337.","journal-title":"Psychiatry (Edgmont)"},{"key":"595_CR16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/mpr.79","volume":"9","author":"J Rush","year":"2000","unstructured":"Rush J, Carmody T, Reimitz P. The Inventory of Depressive Symptomatology (IDS): Clinician (IDS-C) and Self-Report (IDS-SR) ratings of depressive symptoms. Int J Methods Psychiatr Res. 2000;9:45\u201359.","journal-title":"Int J Methods Psychiatr Res"},{"key":"595_CR17","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/000841749005700207","volume":"57","author":"M Law","year":"1990","unstructured":"Law M, Baptiste S, McColl M, Opzoomer A, Polatajko H, Pollock N. The Canadian occupational performance measure: an outcome measure for occupational therapy. Can J Occup Ther. 1990;57:82\u20137.","journal-title":"Can J Occup Ther"},{"key":"595_CR18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s40263-013-0041-6","volume":"27","author":"A McTague","year":"2013","unstructured":"McTague A, Cross JH. Treatment of epileptic encephalopathies. CNS Drugs. 2013;27:175\u201384.","journal-title":"CNS Drugs"},{"key":"595_CR19","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ejpn.2011.12.014","volume":"16","author":"H Gimeno","year":"2012","unstructured":"Gimeno H, Tustin K, Selway R, Lin JP. Beyond the Burke-Fahn-Marsden Dystonia Rating Scale. Deep brain stimulation in childhood secondary dystonia. Eur J Paediatr Neurol. 2012;16:501\u20138.","journal-title":"Eur J Paediatr Neurol"},{"key":"595_CR20","doi-asserted-by":"crossref","first-page":"177,014-0177-6","DOI":"10.1186\/s13023-014-0177-6","volume":"9","author":"H Eggink","year":"2014","unstructured":"Eggink H, Kuiper A, Peall KJ, Contarino MF, Bosch AM, Post B, Sival DA, Tijssen MA, de Koning TJ. Rare inborn errors of metabolism with movement disorders: a case study to evaluate the impact upon quality of life and adaptive functioning. Orphanet J Rare Dis. 2014;9:177,014-0177-6.","journal-title":"Orphanet J Rare Dis"},{"key":"595_CR21","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/mds.25339","volume":"28","author":"A Koy","year":"2013","unstructured":"Koy A, Hellmich M, Pauls KA, Marks W, Lin JP, Fricke O, Timmermann L. Effects of deep brain stimulation in dyskinetic cerebral palsy: a meta-analysis. Mov Disord. 2013;28:647\u201354.","journal-title":"Mov Disord"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-017-0595-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T12:01:10Z","timestamp":1498392070000},"score":1,"resource":{"primary":{"URL":"http:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-017-0595-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,7]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["595"],"URL":"https:\/\/doi.org\/10.1186\/s13023-017-0595-3","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,7]]},"article-number":"45"}}